Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.36
MCK's Cash to Debt is ranked higher than
52% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.62 vs. MCK: 0.36 )
MCK' s 10-Year Cash to Debt Range
Min: 0.03   Max: 3.01
Current: 0.36

0.03
3.01
Equity to Asset 0.17
MCK's Equity to Asset is ranked lower than
53% of the 60 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. MCK: 0.17 )
MCK' s 10-Year Equity to Asset Range
Min: 0.17   Max: 0.35
Current: 0.17

0.17
0.35
Interest Coverage 7.81
MCK's Interest Coverage is ranked higher than
57% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.46 vs. MCK: 7.81 )
MCK' s 10-Year Interest Coverage Range
Min: 0.86   Max: 12.77
Current: 7.81

0.86
12.77
F-Score: 6
Z-Score: 4.34
M-Score: -2.21
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 1.56
MCK's Operating margin (%) is ranked higher than
54% of the 61 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.73 vs. MCK: 1.56 )
MCK' s 10-Year Operating margin (%) Range
Min: -0.24   Max: 2
Current: 1.56

-0.24
2
Net-margin (%) 0.81
MCK's Net-margin (%) is ranked higher than
51% of the 61 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.25 vs. MCK: 0.81 )
MCK' s 10-Year Net-margin (%) Range
Min: -0.19   Max: 3.07
Current: 0.81

-0.19
3.07
ROE (%) 15.39
MCK's ROE (%) is ranked higher than
84% of the 57 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.40 vs. MCK: 15.39 )
MCK' s 10-Year ROE (%) Range
Min: -3   Max: 22.45
Current: 15.39

-3
22.45
ROA (%) 2.85
MCK's ROA (%) is ranked higher than
61% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.88 vs. MCK: 2.85 )
MCK' s 10-Year ROA (%) Range
Min: -0.9   Max: 7.44
Current: 2.85

-0.9
7.44
ROC (Joel Greenblatt) (%) 86.10
MCK's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 61 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.71 vs. MCK: 86.10 )
MCK' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -5.31   Max: 195.85
Current: 86.1

-5.31
195.85
Revenue Growth (%) 11.50
MCK's Revenue Growth (%) is ranked higher than
75% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. MCK: 11.50 )
MCK' s 10-Year Revenue Growth (%) Range
Min: -18.4   Max: 38.5
Current: 11.5

-18.4
38.5
EBITDA Growth (%) 20.60
MCK's EBITDA Growth (%) is ranked higher than
73% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.10 vs. MCK: 20.60 )
MCK' s 10-Year EBITDA Growth (%) Range
Min: -47.9   Max: 146.7
Current: 20.6

-47.9
146.7
EPS Growth (%) 10.80
MCK's EPS Growth (%) is ranked higher than
62% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.80 vs. MCK: 10.80 )
MCK' s 10-Year EPS Growth (%) Range
Min: -44.5   Max: 87.1
Current: 10.8

-44.5
87.1
» MCK's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

MCK Guru Trades in Q4 2013

Andreas Halvorsen 1,261,574 sh (New)
Pioneer Investments 203,529 sh (+1217.6%)
Ray Dalio 56,630 sh (+30.7%)
Jeremy Grantham 341,518 sh (+13.83%)
Leon Cooperman 693,482 sh (+0.3%)
John Buckingham Sold Out
Mario Gabelli Sold Out
Vanguard Health Care Fund 7,449,500 sh (-11.73%)
Scott Black 68,116 sh (-17.78%)
Larry Robbins 3,050,925 sh (-33.86%)
Joel Greenblatt 21,358 sh (-45.81%)
Steven Cohen 97,098 sh (-66%)
Paul Tudor Jones 28,513 sh (-85.74%)
Jim Simons 45,400 sh (-91.92%)
» More
Q1 2014

MCK Guru Trades in Q1 2014

John Burbank 1,302 sh (New)
Mario Gabelli 11,520 sh (New)
Joel Greenblatt 44,157 sh (+106.75%)
Pioneer Investments 402,758 sh (+97.89%)
Leon Cooperman 710,982 sh (+2.52%)
Jim Simons Sold Out
Andreas Halvorsen Sold Out
Vanguard Health Care Fund 7,343,200 sh (-1.43%)
Scott Black 63,383 sh (-6.95%)
Larry Robbins 2,408,550 sh (-21.06%)
Ray Dalio 31,030 sh (-45.21%)
Steven Cohen 12,995 sh (-86.62%)
Paul Tudor Jones 1,300 sh (-95.44%)
Jeremy Grantham 9,600 sh (-97.19%)
» More
Q2 2014

MCK Guru Trades in Q2 2014

Lee Ainslie 1,719,923 sh (New)
Jim Simons 461,900 sh (New)
Paul Tudor Jones 79,317 sh (+6001.31%)
Mario Gabelli 14,560 sh (+26.39%)
Larry Robbins 2,837,666 sh (+17.82%)
Pioneer Investments 465,693 sh (+15.63%)
Steven Cohen 301,500 sh (unchged)
Larry Robbins 250,000 sh (unchged)
John Burbank Sold Out
Jeremy Grantham 9,200 sh (-4.17%)
Leon Cooperman 669,775 sh (-5.8%)
Vanguard Health Care Fund 6,584,000 sh (-10.34%)
Scott Black 44,542 sh (-29.73%)
Joel Greenblatt 20,104 sh (-54.47%)
Ray Dalio 4,030 sh (-87.01%)
» More
Q3 2014

MCK Guru Trades in Q3 2014

Louis Moore Bacon 40,000 sh (New)
Jeremy Grantham 227,600 sh (+2373.91%)
Ray Dalio 17,713 sh (+339.53%)
Lee Ainslie 1,857,273 sh (+7.99%)
Joel Greenblatt Sold Out
Pioneer Investments 464,326 sh (-0.29%)
Leon Cooperman 652,175 sh (-2.63%)
Scott Black 43,133 sh (-3.16%)
Mario Gabelli 14,040 sh (-3.57%)
Vanguard Health Care Fund 6,342,800 sh (-3.66%)
Larry Robbins 1,866,966 sh (-34.21%)
Paul Tudor Jones 50,000 sh (-36.96%)
Jim Simons 161,100 sh (-65.12%)
Steven Cohen 85,100 sh (-71.77%)
» More
» Details

Insider Trades

Latest Guru Trades with MCK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Lee Ainslie 2014-09-30 Add 7.99%0.39%$186.58 - $199.63 $ 205.176%1857273
Vanguard Health Care Fund 2014-09-30 Reduce -3.66%0.12%$186.58 - $199.63 $ 205.176%6342800
Joel Greenblatt 2014-09-30 Sold Out 0.05%$186.58 - $199.63 $ 205.176%0
Ray Dalio 2014-09-30 Add 339.53%0.02%$186.58 - $199.63 $ 205.176%17713
Lee Ainslie 2014-06-30 New Buy4.6%$164.68 - $191.63 $ 205.1715%1719923
Vanguard Health Care Fund 2014-06-30 Reduce -10.34%0.37%$164.68 - $191.63 $ 205.1715%6584000
Scott Black 2014-06-30 Reduce -29.73%0.36%$164.68 - $191.63 $ 205.1715%44542
Joel Greenblatt 2014-06-30 Reduce -54.47%0.07%$164.68 - $191.63 $ 205.1715%20104
Ray Dalio 2014-06-30 Reduce -87.01%0.04%$164.68 - $191.63 $ 205.1715%4030
John Burbank 2014-06-30 Sold Out 0.01%$164.68 - $191.63 $ 205.1715%0
Mario Gabelli 2014-06-30 Add 26.39%$164.68 - $191.63 $ 205.1715%14560
Andreas Halvorsen 2014-03-31 Sold Out 0.95%$160.16 - $185.35 $ 205.1718%0
Joel Greenblatt 2014-03-31 Add 106.75%0.06%$160.16 - $185.35 $ 205.1718%44157
Ray Dalio 2014-03-31 Reduce -45.21%0.03%$160.16 - $185.35 $ 205.1718%31030
Mario Gabelli 2014-03-31 New Buy0.01%$160.16 - $185.35 $ 205.1718%11520
John Burbank 2014-03-31 New Buy0.01%$160.16 - $185.35 $ 205.1718%1302
Andreas Halvorsen 2013-12-31 New Buy0.95%$129.57 - $165.89 $ 205.1733%1261574
Vanguard Health Care Fund 2013-12-31 Reduce -11.73%0.43%$129.57 - $165.89 $ 205.1733%7449500
Scott Black 2013-12-31 Reduce -17.78%0.21%$129.57 - $165.89 $ 205.1733%68116
Joel Greenblatt 2013-12-31 Reduce -45.81%0.07%$129.57 - $165.89 $ 205.1733%21358
Ray Dalio 2013-12-31 Add 30.7%0.02%$129.57 - $165.89 $ 205.1733%56630
Mario Gabelli 2013-12-31 Sold Out $129.57 - $165.89 $ 205.1733%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about McKesson Corp

Weekly Insider Sells Highlight: HCA, MCK, P, ROP
According to GuruFocus Insider Data, the largest insider sells during the past week were: HCA Holdings Inc., McKesson Corp, Pandora Media Inc. and Roper Industries Inc. Read more...
Scott Black’s Barron’s Roundtable Stock Picks Report Card
Every year Barron’s gets its Roundtable team together and they discuss stock picks and the status of the economy in general.  Guru Scott Black (Trades, Portfolio) is a member of Barron’s Roundtable team, and the following stocks are his stock picks for 2013 and how they ended up doing for the year.  Read more...
King of Consistency - Larry Robbins’ High Conviction Stocks in Review
To ring in the New Year, here’s inspiration from hedge fund hotshot Larry Robbins who once said: “Consistency of effort often makes the difference between who wins and who loses …We know that the key is to realize that on January 1st, when the sheet reads zero point zero, we have to remember that it’s not about what you did before, but about that persistence and continuity of work effort.” Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 36.80
MCK's P/E(ttm) is ranked higher than
65% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.90 vs. MCK: 36.80 )
MCK' s 10-Year P/E(ttm) Range
Min: 8.15   Max: 36.77
Current: 36.8

8.15
36.77
P/B 5.33
MCK's P/B is ranked higher than
56% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.75 vs. MCK: 5.33 )
MCK' s 10-Year P/B Range
Min: 1.29   Max: 5.33
Current: 5.33

1.29
5.33
P/S 0.30
MCK's P/S is ranked higher than
87% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.81 vs. MCK: 0.30 )
MCK' s 10-Year P/S Range
Min: 0.03   Max: 0.32
Current: 0.3

0.03
0.32
PFCF 23.88
MCK's PFCF is ranked higher than
80% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 205.00 vs. MCK: 23.88 )
MCK' s 10-Year PFCF Range
Min: 4.61   Max: 41.74
Current: 23.88

4.61
41.74
EV-to-EBIT 22.22
MCK's EV-to-EBIT is ranked higher than
69% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.60 vs. MCK: 22.22 )
MCK' s 10-Year EV-to-EBIT Range
Min: -153.6   Max: 22.5
Current: 22.22

-153.6
22.5
PEG 2.79
MCK's PEG is ranked higher than
77% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.38 vs. MCK: 2.79 )
MCK' s 10-Year PEG Range
Min: 0.18   Max: 4.43
Current: 2.79

0.18
4.43
Shiller P/E 38.46
MCK's Shiller P/E is ranked higher than
76% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 42.66 vs. MCK: 38.46 )
MCK' s 10-Year Shiller P/E Range
Min: 12.57   Max: 42.09
Current: 38.46

12.57
42.09
Current Ratio 1.15
MCK's Current Ratio is ranked lower than
53% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.54 vs. MCK: 1.15 )
MCK' s 10-Year Current Ratio Range
Min: 1.08   Max: 1.59
Current: 1.15

1.08
1.59
Quick Ratio 0.68
MCK's Quick Ratio is ranked lower than
53% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.13 vs. MCK: 0.68 )
MCK' s 10-Year Quick Ratio Range
Min: 0.52   Max: 0.94
Current: 0.68

0.52
0.94

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.47
MCK's Dividend Yield is ranked lower than
92% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.63 vs. MCK: 0.47 )
MCK' s 10-Year Dividend Yield Range
Min: 0.35   Max: 1.42
Current: 0.47

0.35
1.42
Dividend Payout 0.16
MCK's Dividend Payout is ranked higher than
93% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.72 vs. MCK: 0.16 )
MCK' s 10-Year Dividend Payout Range
Min: 0.04   Max: 6
Current: 0.16

0.04
6
Dividend growth (3y) 8.50
MCK's Dividend growth (3y) is ranked higher than
63% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.90 vs. MCK: 8.50 )
MCK' s 10-Year Dividend growth (3y) Range
Min: -21.7   Max: 44.2
Current: 8.5

-21.7
44.2
Yield on cost (5-Year) 1.01
MCK's Yield on cost (5-Year) is ranked lower than
80% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.58 vs. MCK: 1.01 )
MCK' s 10-Year Yield on cost (5-Year) Range
Min: 0.71   Max: 2.87
Current: 1.01

0.71
2.87
Share Buyback Rate 4.00
MCK's Share Buyback Rate is ranked higher than
88% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.30 vs. MCK: 4.00 )
MCK' s 10-Year Share Buyback Rate Range
Min: 4.3   Max: -43.4
Current: 4

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.34
MCK's Price/DCF (Projected) is ranked higher than
79% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.72 vs. MCK: 1.34 )
MCK' s 10-Year Price/DCF (Projected) Range
Min: 0.6   Max: 35.16
Current: 1.34

0.6
35.16
Price/Median PS Value 1.75
MCK's Price/Median PS Value is ranked higher than
55% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.30 vs. MCK: 1.75 )
MCK' s 10-Year Price/Median PS Value Range
Min: 0.01   Max: 4.66
Current: 1.75

0.01
4.66
Price/Peter Lynch Fair Value 2.75
MCK's Price/Peter Lynch Fair Value is ranked higher than
80% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 9999.00 vs. MCK: 2.75 )
MCK' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.34   Max: 69.98
Current: 2.75

0.34
69.98
Earnings Yield (Greenblatt) 4.50
MCK's Earnings Yield (Greenblatt) is ranked higher than
67% of the 61 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. MCK: 4.50 )
MCK' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.4   Max: 16.5
Current: 4.5

4.4
16.5
Forward Rate of Return (Yacktman) 15.24
MCK's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.50 vs. MCK: 15.24 )
MCK' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1307.9   Max: 90.9
Current: 15.24

-1307.9
90.9

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, CAH, SHTDF, HSIC, PDCO » details
Traded in other countries:MCK.Germany, MCK.Mexico
McKesson Corporation is a Delaware Corporation. The Company delivers pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs. The Company operates in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment and health and beauty care products throughout North America and internationally. This segment provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. This segment also provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers through a network of distribution centers within the U.S. In addition, this segment sells financial, operational and clinical solutions for pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing and other services. The McKesson Technology Solutions segment includes McKesson Health Solutions, which includes its InterQual clinical criteria solution, claims payment solutions and network performance tools. This segment also delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. This segment's customers include hospitals, physicians, homecare providers, retail pharmacies and payers primarily from North America. McKesson Distribution Solutions consists of the following businesses: North America pharmaceutical distribution and services, International pharmaceutical distribution and services and Medical Surgical distribution and services. The Company competes with other software services firms, consulting firms, shared service vendors, certain hospitals and hospital groups, payers, care management organizations, hardware vendors and internet-based companies with technology applicable to the healthcare industry.
» More Articles for MCK

Headlines

Articles On GuruFocus.com
Weekly Insider Sells Highlight: FB, DVA, DATA, MCK, TXN Nov 18 2014 
Weekly Highlight of CEO Sells Oct 13 2014 
Campbell Soup's ROE is Really Attractive Oct 09 2014 
A Top Growing Soup Company Oct 08 2014 
Rite Aid Corporation is Going in the Right Direction Aug 20 2014 
Rite Aid Corporation is Destined for Greatness Jul 07 2014 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
Weekly Insider Sells Highlight: HCA, MCK, P, ROP Jun 02 2014 
Rite Aid Corporation May Be a Buy: More Upside Expected May 20 2014 
Vanguard Health Care Fund’s Top Five Feb 10 2014 

More From Other Websites
NovaBay Signs Distribution Agreement with McKesson For i-Lid Cleanser Nov 17 2014
NovaBay Signs Distribution Agreement with McKesson for i-Lid Cleanser Nov 17 2014
5 Trade Ideas for Monday: Aetna, Altera, Alliance Resource Partners, McKesson and Valeant... Nov 16 2014
Community IT Outsourcing from McKesson Now Generally Available Nov 13 2014
How Top CIOs Brace For The Next Big Data Breach Nov 12 2014
Baylor Scott & White Health Selects McKesson Performance Analytics™ for Enterprise Decision... Nov 12 2014
MCKESSON CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 10 2014
MCKESSON CORP Financials Nov 04 2014
Three Reasons HP's IT Chief Says The CIO Of The Future Is A 'Broker,' Not A 'Builder' Nov 03 2014
10-Q for McKesson Corp. Oct 30 2014
AmerisourceBergen Earnings Growth Keeps Accelerating Oct 30 2014
Mckesson (MCK) Earnings Report: Q2 2015 Conference Call Transcript Oct 29 2014
McKesson Beats on Q2 Earnings, Revenues; Keeps Guidance Oct 29 2014
McKesson tops Street 2Q forecasts Oct 28 2014
McKesson tops Street 2Q forecasts Oct 28 2014
[$$] McKesson Profit Up Oct 28 2014
McKesson Reports Fiscal 2015 Second-Quarter Results Oct 28 2014
MCKESSON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 28 2014
McKesson Reports Fiscal 2015 Second-Quarter Results Oct 28 2014
McKesson (MCK) Hits New Lifetime High Today Oct 28 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK